Breast cancer screening halves the risk of breast cancer death: A case-referent study

E Paap, ALM Verbeek, AAM Botterweck, HJ van Doorne-Nagtegaal, M Imhof-Tas, Harry de Koning, Suzie Otto, L de Munck, Alexander Steen, R Holland, GJ den Heeten, MJM Broeders

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Scopus)


Large-scale epidemiologic studies have consistently demonstrated the effectiveness of mammographic screening programs, however the benefits are still subject to debate. We estimated the effect of the Dutch screening program on breast cancer mortality. In a large multi-region case-referent study, we identified all breast cancer deaths in 2004 and 2005 in women aged 50-75 who had been invited for screening (cases). Cases were individually matched to referents from the population invited to screening. Conditional logistic regression was used to estimate the odds ratio (OR) of breast cancer death according to individual screening history. The OR was adjusted for self-selection bias using regional correction factors for the difference in baseline risk for breast cancer death between screened and unscreened women. A total of 1233 cases and 2090 referents were included in this study. We found a 58% reduction in breast cancer mortality in screened versus unscreened women (adjusted OR = 0.42, 95% CI 033-0.53). Screening, i.e. early detection and treatment, has resulted in a substantial reduction in breast cancer mortality, indicating that the Dutch breast cancer screening program is highly effective. (C) 2014 Elsevier Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)439-444
Number of pages6
Issue number4
Publication statusPublished - 2014

Research programs

  • EMC NIHES-02-65-01

Cite this